遗传风险儿童胰岛自身免疫与1型糖尿病的生长发育轨迹
本研究基于TRIGR随机婴儿喂养试验的2149名遗传高风险儿童,从出生随访至10-14岁,评估童年期体重与身长/身高增长与胰岛自身免疫(IA)及1型糖尿病的关系。结果显示年度生长指标与IA无关,但2-10岁超重与1型糖尿病风险增加相关(HR 2.39;95%CI 1.46, 3.92;p<0.001)。
要点
- 2-10岁超重与1型糖尿病风险增加约2倍相关,但与胰岛自身免疫发生无关。
- 年度生长指标与胰岛自身免疫无显著关联。
- 未来需研究体重管理策略对上述结局的影响。
核心结论
- 在遗传高风险儿童中,2-10岁超重与从多个胰岛自身免疫进展为1型糖尿病及1型糖尿病发生风险增加相关,但与胰岛自身免疫发生无关。
研究设计与样本
- 随机婴儿喂养试验(TRIGR,N=2149)的二次分析,每12个月测量体重和身长/身高,随访至10-14岁。
- 采用Cox比例风险回归(校正出生体重和身长z评分、性别、HLA风险、母亲1型糖尿病、分娩方式、母乳喂养时长,并按地区分层)及联合模型分析。
主要发现
- 305名(14.2%)发生胰岛自身免疫,172名(8%)发生1型糖尿病。
- 10岁时超重(含肥胖)比例为28%,仅肥胖比例为9%。
- 年度生长指标与胰岛自身免疫无关联。
- 2-10岁超重与1型糖尿病风险增加相关(HR 2.39;95%CI 1.46, 3.92;p<0.001,时变Cox回归),联合模型结果相似。
临床怎么用
- 对1型糖尿病遗传高风险儿童,关注2-10岁体重管理可能有助于降低1型糖尿病进展风险。
局限性
- 本研究为二次分析,需未来研究评估体重管理策略对结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to evaluate the relationship between childhood growth measures and risk of developing islet autoimmunity (IA) and type 1 diabetes in children with an affected first-degree relative and increased HLA-conferred risk. We hypothesised that being overweight or obese during childhood is associated with a greater risk of IA and type 1 diabetes. METHODS: Participants in a randomised infant feeding trial (N = 2149) were measured at 12 month intervals for weight and length/height and followed for IA (at least one positive out of insulin autoantibodies, islet antigen-2 autoantibody, GAD autoantibody and zinc transporter 8 autoantibody) and development of type 1 diabetes from birth to 10-14 years. In this secondary analysis, Cox proportional hazard regression models were adjusted for birthweight and length z score, sex, HLA risk, maternal type 1 diabetes, mode of delivery and breastfeeding duration, and stratified by residence region (Australia, Canada, Northern Europe, Southern Europe, Central Europe and the USA). Longitudinal exposures were studied both by time-varying Cox proportional hazard regression and by joint modelling. Multiple testing was considered using family-wise error rate at 0.05. RESULTS: In the Trial to Reduce IDDM in the Genetically at Risk (TRIGR) population, 305 (14.2%) developed IA and 172 (8%) developed type 1 diabetes. The proportions of children overweight (including obese) and obese only were 28% and 9% at 10 years, respectively. Annual growth measures were not associated with IA, but being overweight at 2-10 years of life was associated with a twofold increase in the development of type 1 diabetes (HR 2.39; 95% CI 1.46, 3.92; p < 0.001 in time-varying Cox regression), and similarly with joint modelling. CONCLUSIONS/INTERPRETATION: In children at genetic risk of type 1 diabetes, being overweight at 2-10 years of age is associated with increased risk of progression from multiple IA to type 1 diabetes and with development of type 1 diabetes, but not with development of IA. Future studies should assess the impact of weight management strategies on these outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT00179777.
引用
- Nucci AM, Virtanen SM, Cuthbertson D, et al. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk. Diabetologia. 2021. PMID: 33474583. doi:10.1007/s00125-020-05358-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。